Another bumper week for ETF launches saw 11 new funds from BMO Asset Management, including a suite of ETFs focused on innovation, plus four new Xtrackers funds providing access to US companies with a sector focus and Eurozone companies with a focus on sustainability. Staying with the ESG/sustainability theme we also have a new Japanese equities ETF from Amundi, plus a corporate bonds fund from L&G. The latest offering from Horizons ETFs meanwhile offers investors a trip into the world of companies looking at the use of psychedelic compounds, such as psilocybin and ketamine, as treatment for mental illness and other medical conditions.
Another bumper week for ETF launches saw 11 new funds from BMO Asset Management, including a suite of ETFs focused on innovation, plus four new Xtrackers funds providing access to US companies with a sector focus and Eurozone companies with a focus on sustainability. Staying with the ESG/sustainability theme we also have a new Japanese equities ETF from Amundi, plus a corporate bonds fund from L&G. The latest offering from Horizons ETFs meanwhile offers investors a trip into the world of companies looking at the use of psychedelic compounds, such as psilocybin and ketamine, as treatment for mental illness and other medical conditions.
Xtrackers launches four new ETFs on Xetra focussed on Eurozone and US companies
Amundi launches new Japanese equities ETF with ESG focus and currency hedging
Horizons ETFs to launch world’s first psychedelics-focused ETF
ProShares launches its first leveraged thematic ETFs
L&G launches corporate bonds ETFs with sustainability filter on Xetra
